Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 147 citing articles:

The Metabolic Underpinnings of Ferroptosis
Jiashuo Zheng, Marcus Conrad
Cell Metabolism (2020) Vol. 32, Iss. 6, pp. 920-937
Open Access | Times Cited: 967
Ferroptosis at the intersection of lipid metabolism and cellular signaling
Deguang Liang, Alexander M. Minikes, Xuejun Jiang
Molecular Cell (2022) Vol. 82, Iss. 12, pp. 2215-2227
Open Access | Times Cited: 666
Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention
Lisa M. Butler, Ylenia Perone, Jonas Dehairs, et al.
Advanced Drug Delivery Reviews (2020) Vol. 159, pp. 245-293
Open Access | Times Cited: 472
Peroxidation of n-3 and n-6 polyunsaturated fatty acids in the acidic tumor environment leads to ferroptosis-mediated anticancer effects
Emeline Dierge, Elena Debock, Céline Guilbaud, et al.
Cell Metabolism (2021) Vol. 33, Iss. 8, pp. 1701-1715.e5
Open Access | Times Cited: 331
Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy
Fan Yang, Yi Xiao, Jia-Han Ding, et al.
Cell Metabolism (2022) Vol. 35, Iss. 1, pp. 84-100.e8
Open Access | Times Cited: 326
The cell biology of ferroptosis
Scott J. Dixon, James A. Olzmann
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 6, pp. 424-442
Closed Access | Times Cited: 305
Tumour fatty acid metabolism in the context of therapy resistance and obesity
Andrew J. Hoy, Shilpa R. Nagarajan, Lisa M. Butler
Nature reviews. Cancer (2021) Vol. 21, Iss. 12, pp. 753-766
Closed Access | Times Cited: 260
Regulation of ferroptosis by lipid metabolism
Lauren E. Pope, Scott J. Dixon
Trends in Cell Biology (2023) Vol. 33, Iss. 12, pp. 1077-1087
Closed Access | Times Cited: 228
Ferroptosis Inducers Are a Novel Therapeutic Approach for Advanced Prostate Cancer
Ali Ghoochani, En‐Chi Hsu, Merve Aslan, et al.
Cancer Research (2021) Vol. 81, Iss. 6, pp. 1583-1594
Open Access | Times Cited: 219
The diversity and breadth of cancer cell fatty acid metabolism
Shilpa R. Nagarajan, Lisa M. Butler, Andrew J. Hoy
Cancer & Metabolism (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 147
Lipid Metabolism in Ferroptosis
Zhi Lin, Jiao Liu, Rui Kang, et al.
Advanced Biology (2021) Vol. 5, Iss. 8
Closed Access | Times Cited: 108
Ferroptosis in health and disease
Carsten Berndt, Hamed Alborzinia, Vera Skafar Amen, et al.
Redox Biology (2024) Vol. 75, pp. 103211-103211
Open Access | Times Cited: 75
Lipid droplets and polyunsaturated fatty acid trafficking: Balancing life and death
Mauro Danielli, Leja Perne, Eva Jarc, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 69
Role of mitochondrial metabolic disorder and immune infiltration in diabetic cardiomyopathy: new insights from bioinformatics analysis
Cheng Peng, Yanxiu Zhang, Xueyan Lang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 62
Mechanisms and regulations of ferroptosis
Xu-Dong Zhang, Zhongyuan Liu, Mao-Sen Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 56
Ferroptosis Nanomedicine: Clinical Challenges and Opportunities for Modulating Tumor Metabolic and Immunological Landscape
Huocheng Yang, Xuemei Yao, Yingqi Liu, et al.
ACS Nano (2023) Vol. 17, Iss. 16, pp. 15328-15353
Closed Access | Times Cited: 53
Inhibition of phosphoglycerate dehydrogenase induces ferroptosis and overcomes enzalutamide resistance in castration-resistant prostate cancer cells
Jinxiang Wang, Leli Zeng, Nisha Wu, et al.
Drug Resistance Updates (2023) Vol. 70, pp. 100985-100985
Open Access | Times Cited: 51
Emerging targets in lipid metabolism for cancer therapy
Alexander R. Terry, Nissim Hay
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 6, pp. 537-551
Open Access | Times Cited: 22
Energy metabolism in health and diseases
Hui Liu, Shuo Wang, Jianhua Wang, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 8
DTX2 attenuates Lenvatinib-induced ferroptosis by suppressing docosahexaenoic acid biosynthesis through HSD17B4-dependent peroxisomal β-oxidation in hepatocellular carcinoma
Zhongyan Zhang, Qi Zhou, Zhenchong Li, et al.
Drug Resistance Updates (2025) Vol. 81, pp. 101224-101224
Closed Access | Times Cited: 2
IL-9/STAT3/fatty acid oxidation–mediated lipid peroxidation contributes to Tc9 cell longevity and enhanced antitumor activity
Liuling Xiao, Xingzhe Ma, Lingqun Ye, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 7
Open Access | Times Cited: 64
Targeting Ferroptosis Pathway to Combat Therapy Resistance and Metastasis of Cancer
Xuan Liu, Yiqian Zhang, Xuyi Wu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 45
SGK2 promotes prostate cancer metastasis by inhibiting ferroptosis via upregulating GPX4
Lulin Cheng, Qingliu He, Bing Liu, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 36
Lipid metabolism alterations and ferroptosis in cancer: Paving the way for solving cancer resistance
Jaewang Lee, Daiha Shin, Jong‐Lyel Roh
European Journal of Pharmacology (2023) Vol. 941, pp. 175497-175497
Closed Access | Times Cited: 31
Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer
Francesco Lasorsa, Nicola Antonio di Meo, Monica Rutigliano, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 910-910
Open Access | Times Cited: 31
Page 1 - Next Page

Scroll to top